tiprankstipranks
Trending News
More News >
Neumora Therapeutics, Inc. (NMRA)
NASDAQ:NMRA
US Market

Neumora Therapeutics, Inc. (NMRA) Cash flow

Compare
351 Followers

Neumora Therapeutics, Inc. Cash Flow

NMRA's free cash flow for Q3 2025 was $-46.65M. For the 2025 fiscal year, NMRA's free cash flow was decreased by $-19.54M and operating cash flow was $-46.63M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -182.94M$ -163.28M$ -114.90M$ -75.42M$ -26.76M
Investing Cash Flow
$ -70.56M$ 64.39M$ -168.01M$ -817.00K$ -11.24M
Financing Cash Flow
$ 21.60M$ 231.94M$ 115.74M$ 293.51M$ 230.10M
End Cash Position
$ 143.36M$ 375.25M$ 242.21M$ 409.37M$ 192.10M
Free Cash Flow
$ -182.94M$ -163.40M$ -115.41M$ -76.24M$ -28.06M
Currency in USD

Neumora Therapeutics, Inc. Cash Flow